Haemonetics Corporation
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, inc…
Medical - Instruments & Supplies
US, Boston [HQ]
Ratios
14 Sheets · From 2023 to 2010Configuration
Margins, Growth Rates In %
| Ratio | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||||||||
| Gross Margin | 52.29 | 52.49 | 50.73 | 48.00 | 49.91 | 47.72 | 44.62 | 42.71 | 45.57 | 43.15 | 49.02 | 45.70 | 50.90 | 52.63 | |
| Profit Margin | 9.04 | 11.82 | 9.19 | 4.35 | 3.75 | 1.86 | -6.11 | -2.96 | 5.04 | 5.69 | 7.74 | 9.13 | 4.37 | 9.87 | |
| Operating Margin | 12.90 | 16.34 | 12.19 | 6.33 | 5.04 | 4.45 | -4.84 | -2.19 | 6.21 | 8.63 | 15.57 | 6.66 | 8.13 | 13.35 | |
|
EPS Growth
|
-1.71 | 38.26 | -18.24 | -41.54 | -10.53 | -51.47 | -430.30 | 53.21 | 268.63 | 24.42 | 41.12 | 3.97 | -45.86 | 167.06 | |
| EPS USD | 115.00 | 159.00 | 130.00 | 76.00 | 68.00 | 33.00 | -109.00 | -51.00 | 86.00 | 107.00 | 151.00 | 157.00 | 85.00 | 227.00 | |
| Return on Assets (ROA) | 7.74 | 9.60 | 7.35 | 2.65 | 2.31 | 1.14 | -4.22 | -2.12 | 3.68 | 4.32 | 6.04 | 4.37 | 2.33 | 5.96 | |
| Return on Equity (ROE) | 9.84 | 11.66 | 9.10 | 5.04 | 4.19 | 2.05 | -7.73 | -3.55 | 6.06 | 8.24 | 13.03 | 10.86 | 5.79 | 14.11 | |
| Return on Invested Capital (ROIC) | 9.73 | 11.62 | 8.98 | 3.51 | 3.58 | 1.75 | -4.06 | -1.76 | 4.27 | 6.13 | 13.94 | 4.39 | 3.61 | 8.04 | |
| Solvency | |||||||||||||||
| Equity Ratio | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Debt/Assets | 2.87 | 0.59 | 0.41 | 32.84 | 28.78 | 28.85 | 30.98 | 25.40 | 20.50 | 27.47 | 30.19 | 38.88 | 41.60 | 39.58 | |
| Debt/Equity | 3.65 | 0.71 | 0.51 | 62.42 | 52.13 | 51.80 | 56.67 | 42.54 | 33.72 | 52.42 | 65.15 | 96.71 | 103.22 | 93.63 | |
| Debt/EBITDA | -123.59 | -120.59 | -265.26 | 495.97 | 518.14 | 659.17 | 231.76 | 135.78 | 50.56 | 93.68 | 92.79 | 362.25 | 303.35 | 193.08 | |
|
Debt/Capitalization
|
3.52 | 0.71 | 0.51 | 38.43 | 34.27 | 34.12 | 36.17 | 29.85 | 25.21 | 34.39 | 39.45 | 49.16 | 50.79 | 48.35 | |
| Long-Term Debt/Capitalization | 0.77 | 0.57 | 0.39 | 37.27 | 31.83 | 32.97 | 33.61 | 25.54 | 7.32 | 32.56 | 34.23 | 48.56 | 42.74 | 47.97 | |
| Interest Debt per Share USD | 0.44 | 0.10 | -1.00 | 8.28 | 8.69 | 8.49 | 8.20 | 6.27 | 4.89 | 6.99 | 7.86 | 14.29 | 15.49 | 15.37 | |
| Debt Growth | 258.58 | -77.47 | -22.71 | 12,631.21 | -8.83 | -2.24 | -4.65 | -22.88 | -19.38 | 38.02 | 9.25 | 85.00 | 9.33 | -1.00 | |
| Liquidity | |||||||||||||||
| Current Ratio | 285.03 | 413.02 | 402.79 | 332.02 | 289.07 | 300.37 | 263.76 | 241.52 | 135.48 | 244.37 | 212.33 | 273.59 | 170.94 | 305.67 | |
| Quick Ratio | 198.50 | 298.03 | 278.66 | 194.24 | 164.67 | 162.08 | 147.37 | 138.42 | 86.14 | 150.31 | 106.41 | 126.18 | 94.71 | 184.55 | |
| Cash Ratio | 107.98 | 181.01 | 175.05 | 99.62 | 88.36 | 84.96 | 62.33 | 66.09 | 46.83 | 71.83 | 48.30 | 75.86 | 58.67 | 112.97 | |
| Operating Cash Flow Ratio | - - | 100 | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | 100 | |
| Turnover | |||||||||||||||
| Inventory Turnover | 385.16 | 380.97 | 306.07 | 252.39 | 237.85 | 225.49 | 270.65 | 286.91 | 305.98 | 283.04 | 186.46 | 146.50 | 166.43 | 213.42 | |
| Receivables Turnover | 543.82 | 532.13 | 537.30 | 524.36 | 568.93 | 624.28 | 579.07 | 580.36 | 597.73 | 522.94 | 598.33 | 682.42 | 623.18 | 652.37 | |
| Payables Turnover | 1,203.40 | 1,135.07 | 1,012.29 | 929.71 | 877.76 | 982.87 | 1,269.85 | 1,181.26 | 890.28 | 868.11 | 993.43 | 939.74 | 835.51 | 865.90 | |
|
Asset Turnover
|
85.58 | 81.21 | 79.93 | 61.02 | 61.71 | 61.38 | 69.07 | 71.54 | 73.05 | 75.90 | 78.01 | 47.83 | 53.41 | 60.40 | |
| Fixed Turnover | 421.03 | 435.09 | 450.24 | 347.14 | 345.76 | 282.77 | 269.43 | 273.61 | 272.14 | 281.29 | 390.09 | 400.10 | 384.24 | 375.91 | |
| Coverage | |||||||||||||||
| Interest Coverage | 11,223.85 | 1,842,466.67 | -162.54 | -103.19 | 433.16 | 432.43 | -464.25 | -239.42 | 1,241.04 | 842.87 | 950.37 | 344.32 | 471.64 | 1,066.53 | |
| Asset Coverage | 2,500 | 12,700 | 18,100 | 200 | 200 | 200 | 200 | 200 | 300 | 200 | 200 | 100 | 100 | 100 | |
| Cash Flow Coverage (CFGR) | 603.52 | 2,530.33 | 3,058.02 | 17.72 | 31.88 | 29.72 | 29.87 | 50.77 | 86.86 | 45.49 | 41.36 | 15.38 | 22.27 | 35.65 | |
| EBITDA Coverage | 13,000 | 2,651,200 | -100 | -100 | 400 | 400 | 1,300 | 1,500 | 3,200 | 1,900 | 1,600 | 800 | 900 | 1,700 | |
| Dividend Coverage | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Time Interest Earned (TIE) | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | |
| Market Prospects | |||||||||||||||
| Dividend Yield | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Earnings Yield | 4.06 | 4.79 | 3.79 | 1.81 | 2.12 | 0.74 | -3.10 | -1.26 | 1.18 | 1.22 | 1.50 | 1.40 | 1.33 | 2.75 | |
|
Price/Earnings (P/E)
|
2,462.48 | 2,087.24 | 2,642.35 | 5,513.40 | 4,715.00 | 13,483.30 | -3,230.16 | -7,954.90 | 8,469.14 | 8,193.73 | 6,687.08 | 7,146.29 | 7,514.35 | 3,641.47 | |
| Price/Earnings Growth (PEG) | -1,440.55 | 54.55 | -144.87 | -132.73 | -447.93 | -261.96 | 7.51 | 149.50 | -31.53 | 335.55 | 162.62 | 1,798.48 | -163.85 | 21.80 | |
|
Price/Book (P/B)
|
242.36 | 243.30 | 240.43 | 278.11 | 197.38 | 275.78 | 249.54 | 282.53 | 512.95 | 675.00 | 871.62 | 776.18 | 434.91 | 513.73 | |
| Price/Tangible Book (P/TB) | 242.36 | 243.30 | 240.43 | 278.11 | 197.38 | 275.78 | 249.54 | 282.53 | 512.95 | 675.00 | 871.62 | 776.18 | 434.91 | 513.73 | |
| Price/Sales (P/S) | 222.72 | 246.70 | 242.82 | 239.82 | 176.58 | 250.26 | 197.50 | 235.81 | 426.98 | 465.92 | 517.70 | 652.42 | 328.17 | 359.58 | |
|
Price/Cash Flow (P/CF)
|
1,100.10 | 1,352.21 | 1,532.60 | 2,514.52 | 1,187.77 | 1,791.41 | 1,474.27 | 1,308.14 | 1,751.56 | 2,830.29 | 3,234.39 | 5,219.51 | 1,892.08 | 1,538.97 | |
| Price/Free CF (P/FCF) | 1,933.02 | 2,174.06 | 2,845.08 | 9,347.20 | 2,515.68 | 45,951.47 | 9,232.34 | 2,499.42 | 2,651.69 | 11,180.82 | 4,675.14 | 7,913.44 | 4,302.55 | 2,580.20 | |
| Price/Operating CF (P/OCF) | 1,100.10 | 1,352.21 | 1,532.60 | 2,514.52 | 1,187.77 | 1,791.41 | 1,474.27 | 1,308.14 | 1,751.56 | 2,830.29 | 3,234.39 | 5,219.51 | 1,892.08 | 1,538.97 |